Area of research
Surgery · Cancer Research
Research interest
Research focused on Prostate cancer and Bladder cancer, with related work in Breast cancer, Prostatitis, Goserelin. Notable publications include 'Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3', 'Age-Dependent Association between Sex and Renal Cell Carcinoma Mortality: a Population-Based Analysis', and 'Longitudinal MRI‐Driven Multi‐Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer'.
Longitudinal MRI‐Driven Multi‐Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer
Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study
Clinical significance of urine prostatic exosomal protein in the diagnosis of prostate cancer.
PubMed 2019cited by 9position: first
Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3
Age-Dependent Association between Sex and Renal Cell Carcinoma Mortality: a Population-Based Analysis